CD274 Transcription

Stable Identifier
R-HSA-9909623
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The transcriptional regulation of CD274 (PD-L1/programmed death-ligand 1) is crucial in cancer biology, enabling tumor cells to evade immune detection. PD-L1 expression is tightly controlled by various transcription factors and signalling pathways responding to both intrinsic cellular signals and extrinsic environmental perturbations. It is regulated transcriptionally by multiple mechanisms, including epigenetic modifications (EZH2, DNMTs, MLLs) and transcription factors (STAT3, STAT1, IRF1, MYC, HIF, and others) activated by various upstream signalling pathways. The regulation of PD-L1 is a complex interplay of oncogenic signalling pathways, cytokine responses, epigenetic modifications, specific transcription factors, the tumor microenvironment, and non-coding RNAs. This multifaceted regulation finely tunes PD-L1 expression to promote immune evasion in cancer, making it a critical target for cancer immunotherapy (Zhou et al., 2023, Cha et al.,2019, Yamaguchi et al.,2022, Ju et al., 2020).
Literature References
PubMed ID Title Journal Year
32064150 Regulation of PD-L1 expression in cancer and clinical implications in immunotherapy

Ju, X, Zhang, H, Zhou, Z, Wang, Q

Am J Cancer Res 2020
31668929 Mechanisms Controlling PD-L1 Expression in Cancer

Cha, JH, Chan, LC, Li, CW, Hsu, JL, Hung, MC

Mol Cell 2019
35132224 Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics

Yamaguchi, H, Hsu, JM, Yang, WH, Hung, MC

Nat Rev Clin Oncol 2022
37228770 PD-L1: expression regulation

Zhou, YJ, Li, G, Wang, J, Liu, M, Wang, Z, Song, Y, Zhang, X, Wang, X

Blood Sci 2023
32504749 PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs

Ashrafizadeh, M, Zarrabi, A, Hushmandi, K, Zarrin, V, Moghadam, ER, Zabolian, A, Tavakol, S, Samarghandian, S, Najafi, M

Life Sci 2020
Participants
Participates
This event is regulated
Authored
Reviewed
Created
Cite Us!